Milestone Pharmaceuticals, Inc. MIST
NASDAQ · United States · Health Technology
$0.8316-0.03 (-3.94%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.21 | -0.20 | -7.7% | $559.00K | -31.6% | -15.7%$1.27→$1.07 |
| Q1 2026 | 2026-05-13 | -0.20 | 0.19 | -205.3% | — | — | -14.2%$1.90→$1.63 |
| Q4 2025 | 2026-03-20 | -0.15 | -0.18 | +16.7% | — | — | -25.9%$1.70→$1.26 |
| Q3 2025 | 2025-11-12 | -0.12 | -0.17 | +29.4% | — | — | -0.5%$1.91→$1.90 |
| Q2 2025 | 2025-08-12 | -0.20 | -0.18 | -11.1% | — | — | — |
| Q1 2025 | 2025-05-14 | -0.31 | -0.19 | -63.2% | — | — | — |
| Q4 2024 | 2025-03-13 | -0.19 | -0.15 | -26.7% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.14 | -0.18 | +22.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.